COVERAGE ENGINE · PRODUCT + DIAGNOSIS + INSURANCE

How do I get Itvisma
through my insurance?

Itvisma · onasemnogene abeparvovec-brve · One-time intrathecal AAV9 gene therapy

Coverage first → benefit/formulation → assistance
Itvisma is part of the Onasemnogene abeparvovec intrathecal / Itvisma family.

One-time intrathecal AAV9 gene therapy for eligible SMA patients age 2 years and older. ZOLGENSMA remains a separate IV pathway for younger pediatric patients.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

AFTER COVERAGE

Then solve the patient’s out-of-pocket cost.

Financial assistance only helps after the correct product/formulation and benefit path are known.

Novartis Patient Support for ITVISMA →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences and benefit placement can change. Sources in this batch were checked 2026-08-20.

Search another expensive medicine →